Loading…
Sharps Technology, Inc. is projected to rise to $1.87 by 2027, a +1% move from its current price of $1.84. STSS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.77 | $1.84 | $1.92 | -0.01% |
| May 30 | $1.74 | $1.84 | $1.95 | -0.02% |
| May 31 | $1.71 | $1.84 | $1.97 | -0.03% |
| Jun 1 | $1.70 | $1.84 | $1.99 | -0.04% |
| Jun 2 | $1.68 | $1.84 | $2.01 | -0.05% |
| Jun 3 | $1.66 | $1.84 | $2.03 | -0.07% |
| Jun 4 | $1.65 | $1.84 | $2.05 | -0.08% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.65 | $1.84 | $2.05 | -0.08% |
| Week 2 | $1.58 | $1.84 | $2.14 | -0.15% |
| Week 3 | $1.52 | $1.84 | $2.21 | -0.23% |
| Week 4 | $1.48 | $1.83 | $2.27 | -0.31% |
| Week 5 | $1.44 | $1.83 | $2.33 | -0.38% |
| Week 6 | $1.41 | $1.83 | $2.38 | -0.46% |
| Week 7 | $1.38 | $1.83 | $2.43 | -0.53% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sharps Technology, Inc. engages in the marketing and distribution of syringe products and related drug-delivery systems in the United States and internationally. The company operates in two segments, Medical Device Packaging and Digital Asset Treasury.
It distributes and markets safety syringes under the SecureGard, SoloGard, and Provensa brands; prefillable polymer syringes; and pharmaceutical services. The company also engages in executing and managing its treasury platform, which focuses on accumulating Solana. Sharps Technology, Inc.
was incorporated in 2017 and is based in Melville, New York. The company is categorized in Healthcare.
Sharps Technology, Inc. (STSS) is a healthcare company with a current price of $1.81. Its market capitalization is $76.6M and it is ranked 4394 by market cap. The stock sits in a modest price range with near-term volatility typical for a small-cap healthcare name.
A major floor 22.6% below — a decisive break under it would weaken the trend.
The nearest floor, 4.9% below — buyers have tended to step in here.
The nearest ceiling, 13.6% above — a clean break opens room to run.
A major ceiling 28.8% above — clearing it would confirm fresh momentum.
Key STSS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of STSS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.84 | Sell | $1.84 | Buy |
| MA 10 | $1.86 | Sell | $1.86 | Sell |
| MA 20 | $1.88 | Sell | $1.86 | Sell |
| MA 50 | $1.80 | Buy | $1.87 | Sell |
| MA 100 | $1.88 | Sell | $3.48 | Sell |
| MA 200 | $3.68 | Sell | $55.29 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.02 | Neutral |
| Stoch RSI (14) | 21.02 | Neutral |
| CCI (20) | -37.37 | Neutral |
| Williams %R (14) | -78.12 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -8.00 | Sell |
| Bollinger %B (20,2) | 0.39 | Neutral |
| Stochastic %K (14) | 21.88 | Neutral |
| TRIX (15) | 0.20 | Buy |
| Awesome (5,34) | -0.01 | Sell |
| Ultimate (7,14,28) | 45.61 | Neutral |
| Momentum (10) | -0.16 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 1.83 | Buy |
| ADX (14) | 9.55 | Neutral |
| ATR (14) | 0.06 | Info |
Near-term sentiment is NEUTRAL. The RSI(14) is 50, placing the stock in a balanced position. The 50-day simple moving average is $1.80 and the 200-day simple moving average is $3.72, highlighting potential near-term resistance above the current price and support nearby.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.42 | $1.84 | $2.23 | 0% | Neutral | |
| $1.41 | $1.87 | $2.65 | +1% | Neutral | |
| $1.17 | $1.62 | $2.41 | -12% | Neutral | |
| $1.01 | $1.45 | $2.25 | -21% | Bearish | |
| $1.12 | $1.65 | $2.65 | -10% | Neutral | |
| $1.13 | $1.73 | $2.85 | -6% | Neutral | |
| $1.33 | $2.08 | $3.53 | +13% | Neutral | |
| $1.40 | $2.25 | $3.89 | +22% | Bullish | |
| $1.25 | $2.06 | $3.64 | +12% | Neutral | |
| $1.29 | $2.18 | $3.93 | +19% | Neutral | |
| $1.58 | $3.01 | $5.86 | +63% | Bullish | |
| $1.76 | $3.91 | $8.54 | +112% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.42 | $1.84 | $2.18 | +0.00% |
| June 2026 | $1.60 | $1.89 | $2.32 | +2.97% |
| July 2026 | $1.52 | $1.82 | $2.27 | -3.85% |
| August 2026 | $1.43 | $1.73 | $2.19 | -4.96% |
| September 2026 | $1.43 | $1.75 | $2.24 | +1.05% |
| October 2026 | $1.42 | $1.75 | $2.27 | +0.15% |
| November 2026 | $1.36 | $1.68 | $2.20 | -3.96% |
| December 2026 | $1.36 | $1.69 | $2.23 | +0.64% |
Click any year to see its month-by-month STSS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Sharps Technology, Inc.'s 2026 outlook centres on $1.84, within a $1.42 to $2.23 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, STSS could reach as high as $2.65, with a base case around $1.87 and support toward $1.41 — roughly +1% from $1.84. A consolidation phase looks the most probable path here.
Expect STSS to range from $1.17 to $2.41 through 2028. The $1.62 average target implies a -12% move from current prices. That is -13% versus the projected 2027 average. Price action looks broadly range-bound.
The STSS price prediction for 2029 points to an average of $1.45 (low $1.01, high $2.25) — a potential decline of -21% on today's $1.84. Expect choppier, lower action through this leg of the cycle.
In 2030, STSS is projected to trade between $1.12 and $2.65, averaging $1.65 — a potential decline of -10% from today's $1.84. That is up +14% on the projected 2029 average. Price action looks broadly range-bound.
Sharps Technology, Inc.'s 2031 outlook centres on $1.73, within a $1.13 to $2.85 range. That is up +4% on the projected 2030 average. That marks a -6% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, STSS could reach as high as $3.53, with a base case around $2.08 and support toward $1.33 — roughly +13% from $1.84. Price action looks broadly range-bound.
Expect STSS to range from $1.40 to $3.89 through 2033. The $2.25 average target implies a +22% move from current prices. That is up +8% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The STSS price prediction for 2034 points to an average of $2.06 (low $1.25, high $3.64) — a potential gain of +12% on today's $1.84. Price action looks broadly range-bound.
In 2035, STSS is projected to trade between $1.29 and $3.93, averaging $2.18 — a potential gain of +19% from today's $1.84. That is up +6% on the projected 2034 average. A consolidation phase looks the most probable path here.
Sharps Technology, Inc.'s 2040 outlook centres on $3.01, within a $1.58 to $5.86 range. That is up +38% on the projected 2035 average. That marks a +63% change versus current levels. Momentum favours further upside here.
By 2050, STSS could reach as high as $8.54, with a base case around $3.91 and support toward $1.76 — roughly +112% from $1.84. Buyers look set to stay in control over this stretch.
Investing $1,000 in STSS today (≈ 543.478261 STSS) could be worth
$2,122.68
+$1,122.68 (+112%) by 2050 · US Dollar
Based on the average projected STSS price of $3.91 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in STSSwould be worth at today's price.
$1,000 invested in STSS on May 27, 2025 (≈ 261.096611 STSS) would be worth
$480.42
-$519.58 (-52.0%) today · 0.48× · US Dollar
Based on a STSS entry price of $3.83 vs. today's $1.84.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.86 | $989.25 | -1.1% |
| 1 month ago | $1.79 | $1,027.93 | +2.8% |
| 3 months ago | $1.8 | $1,022.22 | +2.2% |
| 6 months ago | $3.23 | $569.66 | -43.0% |
| 1 year ago | $3.83 | $480.42 | -52.0% |
| All time (4.1y) ago | $13,926 | $0.13 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our STSS forecast.
Our base-case forecast reaches $3.70 around 2050.
Implied market cap at $3.70: $156.59M
The multi-year forecast shows a path of gradual change with notable upside in the longer term. In 2026 the average price is $1.81 with 0% ROI and NEUTRAL sentiment. The forecast turns more constructive in the early 2030s, with 2032 averaging $2.06 (13.7% ROI) and 2033 averaging $2.22 (22.5% ROI) as sentiment shifts to BULLISH by 2033.
By 2030 the average is $1.63 with -9.8% ROI and NEUTRAL sentiment, and by 2040 the average rises to $2.93 with 61.9% ROI and BULLISH sentiment. The mid-to-late 2030s show continued upside, with 2034 at $2.02 (11.4% ROI) and 2035 at $2.16 (19.3% ROI). The forecast accelerates further in 2040 and 2050, with 2040 averaging $2.93 and 61.9% ROI and 2050 averaging $3.89 with 114.8% ROI; both years are labeled BULLISH.
By 2032–2035 the path includes Neutral to bullish shifts, culminating in strong upside in the 2040s and 2050s. These figures are estimates and subject to change, with notable volatility implied by an annualized volatility of 80%.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $1.63 with a max of $2.62 and a min of $1.10, resulting in a -9.8% ROI and a NEUTRAL sentiment.
The forecast presents a mixed outlook: near-term values around $1.81 (2026 average, 0% ROI) with negative ROI in 2028 (-12.9%) and 2029 (-20.7%), then turning bullish in later years (2033: 22.5% ROI; 2040: 61.9% ROI; 2050: 114.8% ROI) alongside bullish sentiment for 2033, 2040, and 2050.
Yes. The forecast shows a 2040 max of $5.71 and a 2050 max of $8.50, indicating potential reach of higher price levels in the long term.
RSI(14) is 50 and the sentiment is NEUTRAL. The 50-day SMA is $1.80 and the 200-day SMA is $3.72, with support at $1.73 and resistance at $2.09. The 30-day price range is $1.39 to $2.37, and annualized volatility is 80%.
Current price: $1.81. Market cap: $76.6M. Rank: 4394.
Sharps Technology, Inc. Community Discussion
0Share your Sharps Technology, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.